The pharmaceutical sector is experiencing a important shift in glucose treatment with the emergence of GLP-1 transdermal devices. These innovative vehicles offer a possibly simple alternative to needle injections for individuals managing diabetes. By circumventing the need for frequent needles, GLP-1 skin devices promise to improve user sticking wi